Comments on:

Court won't hear appeal over biotech news release

Back to the article » |
The Supreme Court won't hear an appeal from a CEO convicted because a news release misstated the results of a drug's effectiveness. The high court on Monday declined to hear an appeal from Dr. W. Scott Harkonen, the chief executive of the biotechnology company InterMune Inc. from 1998 until 2003. He was convicted wire fraud in the marketing of the drug Actimmune, which was supposed to fight the...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.